BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26602491)

  • 1. Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab.
    Geller M
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):81-2. PubMed ID: 26602491
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
    Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
    Zazzali JL; Kaplan A; Maurer M; Raimundo K; Trzaskoma B; Solari PG; Antonova E; Mendelson M; Rosén KE
    Ann Allergy Asthma Immunol; 2016 Oct; 117(4):370-377.e1. PubMed ID: 27424128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of omalizumab in severe solar urticaria.
    de Dios-Velázquez Á; González-de Arriba M; Beteta-Gorriti V; Macías E; Campanón-Toro V; Dávila I
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):260-2. PubMed ID: 26803538
    [No Abstract]   [Full Text] [Related]  

  • 5. What are the effects of omalizumab in refractory chronic spontaneous urticaria?
    López M; Navajas-Galimany L
    Medwave; 2015 Dec; 15 Suppl 3():e6346. PubMed ID: 26731420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
    Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Maurer M; Weller K
    Allergy; 2018 Mar; 73(3):576-584. PubMed ID: 29058822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of angio-oedema after omalizumab injections in a patient with chronic spontaneous urticaria.
    Magen E; Chikovani T
    Clin Exp Dermatol; 2018 Oct; 43(7):825. PubMed ID: 29777532
    [No Abstract]   [Full Text] [Related]  

  • 8. Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.
    Faisant C; Du Thanh A; Mansard C; Deroux A; Boccon-Gibod I; Bouillet L
    J Clin Immunol; 2017 Jan; 37(1):80-84. PubMed ID: 27826875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urticaria, Angioedema, and Anaphylaxis.
    Pier J; Bingemann TA
    Pediatr Rev; 2020 Jun; 41(6):283-292. PubMed ID: 32482691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab as Third-Line Therapy for Urticaria During Pregnancy.
    Ensina LF; Cusato-Ensina AP; Camelo-Nunes IC; Solé D
    J Investig Allergol Clin Immunol; 2017; 27(5):326-327. PubMed ID: 29057743
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic urticaria. of hives - how to treat? Hives again and again - how to treat?].
    Stiefelhagen P
    MMW Fortschr Med; 2014 May; 156(9):24. PubMed ID: 24908875
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of chronic urticaria and recurrent Quincke edema].
    Kündig TM
    Ther Umsch; 2001 May; 58(5):321-4. PubMed ID: 11407235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.
    Serarslan G; Uzun M; Doğramacı AÇ; Çelik E
    Dermatol Ther; 2019 Jan; 32(1):e12752. PubMed ID: 30238582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Idiopathic Urticaria.
    Wu EY; Saini SS
    J Allergy Clin Immunol Pract; 2015; 3(6):1003-4; quiz 105. PubMed ID: 26553623
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term omalizumab therapy for refractory chronic spontaneous urticaria: a real-life experience.
    Ensina LF; de Lacerda AE; Machado LM; Camelo-Nunes I; Solé D
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):536. PubMed ID: 26653279
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of refractory cholinergic urticaria with omalizumab.
    Koumaki D; Seaton ED
    Int J Dermatol; 2018 Jan; 57(1):114. PubMed ID: 29057464
    [No Abstract]   [Full Text] [Related]  

  • 17. Solar urticaria treated with omalizumab.
    Schaffenburg WC; Guerrero KT; Marks SN
    Cutis; 2019 Jul; 104(1):E4-E5. PubMed ID: 31487346
    [No Abstract]   [Full Text] [Related]  

  • 18. Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.
    Maurer M; Mathias SD; Crosby RD; Rajput Y; Zazzali JL
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):641-647. PubMed ID: 29567359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory solar urticaria successfully treated with omalizumab with normalization of phototest.
    Combalia A; Fernández-Sartorio C; Aguilera P
    Actas Dermosifiliogr; 2017; 108(6):593-594. PubMed ID: 28168968
    [No Abstract]   [Full Text] [Related]  

  • 20. [Histaminergic angioedema and chronic urticaria].
    Hacard F; Nosbaum A; Bensaid B; Nicolas JF; Augey F; Goujon C; Bérard F
    Presse Med; 2015 Jan; 44(1):37-42. PubMed ID: 25535159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.